Diabetes Mellitus Pharmacotherapy Review

A set of fill-in-the-blank practice questions covering diabetes medication classes, benefits, contraindications, and clinical thresholds.

__________ are the preferred second-line agents in type 2 diabetes for patients with cardiovascular risk factors.

SGLT-2 inhibitors

Empagliflozin provides both glycaemic control and __________.

cardiovascular protection

GLP-1 receptor agonists are contraindicated in patients with a history of __________ due to the risk of recurrence.

pancreatitis

The drug __________ is listed specifically as a GLP-1 receptor agonist.

semgalutide

Insulin is indicated for patients with very poor glycaemic control, where HbA1c is typically >__________.

$$10\%$$

Insulin is also used for patients who have _________.

failed multiple oral agents

In the comparison table, Pioglitazone is noted for leading to __________ HF.

Worse

SGLT-2 inhibitors provide benefit to both the __________ and Kidney based on the summary table.

HF

According to the medication table, both Sulfonylurea and __________ are associated with hypoglycaemia risks.

Insulin

The medication __________ is a specific example of an SGLT-2 inhibitor mentioned.

empagliflozin